Metabolism of Sialic Acid by Bifidobacterium breve UCC2003
- 2014-07-15
- Applied and Environmental Microbiology 80(14)
- PubMed: 24814790
- DOI: 10.1128/AEM.01114-14
Study Design
- Methods
- Transcriptomic and functional genomic analysis.
- Highly Cited
Abstract
Bifidobacteria constitute a specific group of commensal bacteria that inhabit the gastrointestinal tracts of humans and other mammals. Bifidobacterium breve UCC2003 has previously been shown to utilize several plant-derived carbohydrates that include cellodextrins, starch, and galactan. In the present study, we investigated the ability of this strain to utilize the mucin- and human milk oligosaccharide (HMO)-derived carbohydrate sialic acid. Using a combination of transcriptomic and functional genomic approaches, we identified a gene cluster dedicated to the uptake and metabolism of sialic acid. Furthermore, we demonstrate that B. breve UCC2003 can cross feed on sialic acid derived from the metabolism of 3'-sialyllactose, an abundant HMO, by another infant gut bifidobacterial strain, Bifidobacterium bifidum PRL2010.
Research Insights
| Supplement | Dose | Health Outcome | Effect Type | Effect Size | Source |
|---|